BEUDAMED
    Product Code: DLT FDA class 2 21 CFR 862.3650

    Hemagglutination, Opiates

    Clinical Toxicology

    The Hemagglutination test for Opiates is a laboratory immunoassay device that uses red blood cell agglutination reactions to screen for the presence of opiates in patient biological specimens. It is a Class 2 device requiring a 510(k) premarket notification prior to marketing. The product code is DLT, regulated under 21 CFR 862.3650, within the Clinical Toxicology specialty. It is eligible for third-party 510(k) review.

    View on FDA
    510(k)s
    1
    FEI Numbers
    0
    Registration Numbers
    0
    Unique Applicants
    1
    Years Active
    —

    Basic Information

    Product Code
    DLT
    Device Class
    FDA class 2
    Regulation Number
    862.3650
    Medical Specialty
    Clinical Toxicology
    Review Panel
    TX
    Submission Type
    1

    Device Characteristics

    ✗
    GMP Exempt
    ✗
    Implant
    ✗
    Life Sustain/Support
    ✓
    Third Party
    —
    Summary Malfunction Reporting

    510(k) Clearance History

    Loading...

    Related 510(k) Clearances

    This FDA classification is associated with 1 510(k) clearance via K numbers.

    K Number Device Name
    K790400 URINE NEGATIVE CALIBRATOR